Cetera Investment Advisers
OVID icon

Cetera Investment Advisers’s Ovid Therapeutics OVID Stock Holding History

Cetera Investment Advisers’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.7K Hold
17,000
– – ﹤0.01% 4782
2026
Q1 		$37.7K Sell
17,000
-1
-0% -$2 ﹤0.01% 4614
2025
Q4 		$27.7K Buy
17,001
+1
+0% +$2 ﹤0.01% 4558
2025
Q3 		$22.1K Buy
+17,000
New +$14.7K ﹤0.01% 4485
2021
Q2 		– Sell
-17,954
Closed -$72K – 1815
2021
Q1 		$72K Buy
+17,954
New +$59.6K ﹤0.01% 1570

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Cetera Investment Advisers's OVID Position: Q2 2026 in Review

Cetera Investment Advisers held its Ovid Therapeutics (OVID) position steady in Q2 2026 at 17,000 shares worth $45.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4782.

Cetera Investment Advisers first reported a position in OVID in Q1 2021 and has held it in 5 quarters since. The position peaked at $72K in Q1 2021. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Cetera Investment Advisers held 17,000 shares of Ovid Therapeutics worth $45.7K as of Q2 2026.
  • Cetera Investment Advisers left its Ovid Therapeutics share count unchanged in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4782 holding.
  • Cetera Investment Advisers first reported a position in Ovid Therapeutics in Q1 2021 and has held it in 5 quarters since.
  • Cetera Investment Advisers's Ovid Therapeutics position peaked at $72K in Q1 2021.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.